Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Belite BioBLTE | Open-market sale | 06/18 | 06/22 | 10,000 sh5 trades | $145.24avg. | $1,452,399.63 | −40.0% | |
Belite BioBLTE | Open-market sale | 06/16 | 06/17 | 10,000 sh8 trades | $140.57avg. | $1,405,730.11 | −28.6% | |
Belite BioBLTE | Open-market sale10b5-1 plan | 05/07 | 05/08 | 666 sh4 trades | $153.21avg. | $102,038.46 | −100.0% | |
Belite BioBLTE | Open-market sale10b5-1 plan | 05/06 | 05/07 | 1,000 sh6 trades | $153.84avg. | $153,837.8 | −60.0% | |
Belite BioBLTE | Open-market sale10b5-1 plan | 05/05 | 05/06 | 1,000 sh6 trades | $155.50avg. | $155,501.72 | −37.5% | |
Belite BioBLTE | Open-market sale10b5-1 plan | 05/04 | 05/05 | 1,000 sh5 trades | $155.64avg. | $155,638.12 | −27.3% | |
Belite BioBLTE | Open-market sale10b5-1 plan | 05/01 | 05/04 | 1,000 sh8 trades | $155.78avg. | $155,778.97 | −21.4% | |
Belite BioBLTE | Open-market sale10b5-1 plan | 04/30 | 05/01 | 1,000 sh4 trades | $156.97avg. | $156,974.54 | −17.6% | |
Belite BioBLTE | Open-market sale10b5-1 plan | 04/29 | 04/30 | 1,000 sh5 trades | $155.82avg. | $155,816.65 | −15.0% | |
Belite BioBLTE | Open-market sale10b5-1 plan | 04/28 | 04/29 | 1,000 sh9 trades | $159.16avg. | $159,162.45 | −13.0% | |
Belite BioBLTE | Open-market sale10b5-1 plan | 04/27 | 04/28 | 1,000 sh5 trades | $162.64avg. | $162,642.46 | −11.5% | |
Belite BioBLTE | Open-market sale10b5-1 plan | 04/24 | 04/27 | 1,000 sh6 trades | $159.56avg. | $159,556.39 | −10.3% | |
Belite BioBLTE | Open-market sale10b5-1 plan | 04/23 | 04/24 | 1,000 sh6 trades | $166.28avg. | $166,281.64 | −9.4% | |
Belite BioBLTE | Open-market sale10b5-1 plan | 04/22 | 04/23 | 1,000 sh9 trades | $170.39avg. | $170,385.25 | −8.6% | |
Belite BioBLTE | Open-market sale10b5-1 plan | 04/21 | 04/22 | 1,000 sh5 trades | $166.00avg. | $166,000.48 | −7.9% | |
Belite BioBLTE | Open-market sale10b5-1 plan | 04/20 | 04/21 | 1,000 sh7 trades | $163.60avg. | $163,596.12 | −7.3% | |
Belite BioBLTE | Open-market sale10b5-1 plan | 04/16–04/17 | 04/20 | 2,000 sh13 trades | $161.01avg. | $322,011.18 | −12.8% | |
Belite BioBLTE | Open-market sale10b5-1 plan | 04/15 | 04/16 | 1,000 sh5 trades | $168.30avg. | $168,295.94 | −6.0% | |
Belite BioBLTE | Open-market sale10b5-1 plan | 04/09 | 04/13 | 9,200 sh4 trades | $181.45avg. | $1,669,355 | −5.1% | |
Belite BioBLTE | Open-market sale10b5-1 plan | 04/09 | 04/13 | 6,200 sh4 trades | $181.50avg. | $1,125,321.5 | −6.2% |